---
title: "The pharmaceutical sector rises, with multiple stocks hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233548434.md"
description: "The pharmaceutical sector surged, with multiple stocks such as BHC, HC CHEMICAL, and Rundu Pharma hitting the daily limit. ApicHope and Mabwell rose over 8%, while KHPG increased by more than 7%"
datetime: "2025-03-28T02:03:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233548434.md)
  - [en](https://longbridge.com/en/news/233548434.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233548434.md)
generator: "portal-rs"
---

# The pharmaceutical sector rises, with multiple stocks hitting the daily limit

The pharmaceutical sector surged, with multiple stocks such as BHC, HC CHEMICAL, and Rundu Pharma hitting the daily limit. ApicHope and Mabwell rose over 8%, while KHPG increased by more than 7%

### Related Stocks

- [600721.CN](https://longbridge.com/en/quote/600721.CN.md)
- [000953.CN](https://longbridge.com/en/quote/000953.CN.md)
- [002923.CN](https://longbridge.com/en/quote/002923.CN.md)
- [300723.CN](https://longbridge.com/en/quote/300723.CN.md)
- [688062.CN](https://longbridge.com/en/quote/688062.CN.md)
- [002773.CN](https://longbridge.com/en/quote/002773.CN.md)

## Related News & Research

- [Mabwell passes Brazil ANVISA GMP inspection for denosumab biosimilars](https://longbridge.com/en/news/295337739.md)
- [REG - American Century Inv Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group PLC](https://longbridge.com/en/news/296117308.md)
- [YieldMax INTC Option Income Strategy ETF declares $0.642 dividend](https://longbridge.com/en/news/296365803.md)
- [Asia Naphtha/Gasoline-Gasoline timespreads ease slightly; naphtha activity stays thin](https://longbridge.com/en/news/296600248.md)
- [NRED Identifies Stronger Untested IP Targets Beyond 1.67% Copper Trench Mineralization at Wilmac | NREDF Stock News](https://longbridge.com/en/news/296612079.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**